MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Dementia with Lewy bodies (DLB)"

  • 2025 International Congress

    A Longitudinal Quantitative Assessment of Phosphorylated Alpha-Synuclein Deposition in Dementia with Lewy Bodies

    C. Gibbons, T. Levine, B. Bellaire, R. Freeman (boston, USA)

    Objective: To report the quantitative change in cutaneous phosphorylated alpha-synuclein (P-SYN) deposition over time in patients with dementia with Lewy bodies (DLB) in a longitudinal…
  • 2025 International Congress

    Cognitive and Motor Wobbling in Isolated RBD: A Multicentric Study by the International RBD Study Group (IRBDSG)

    A. Stefani, S. Joza, D. Arnaldi, L. Baldelli, G. Benbir, B. Boeve, V. de Cock, L. Churchill, B. Högl, M. Hu, B. Huang, R. Kim, K. Kufer, J-Y. Lee, C. Liguori, B. Mollenhauer, L. Muntean, N. Li, B. Orso, M. Patyjewicz, R. Postuma, F. Provini, S. Lewis, C. Simonet, M. Sommerauer, A. Videnovic, Y. Wing, C. Trenkwalder (Innsbruck, Austria)

    Objective: To define and characterize clinically fluctuating transition phases from isolated RBD (iRBD) to overt alpha-synucleinopathy. Background: Patients with iRBD often develop motor and non-motor…
  • 2025 International Congress

    Patterns and Predictors of Cholinesterase Inhibitor Use in Dementia with Lewy Bodies

    R. Heo, A. Negida, K. Wyman-Chick, J. Bateman, F. Rodriguez-Porcel, B. Berman, N. Mukhopadhyay, M. Barrett (Richmond, USA)

    Objective: The objective of this study was to identify the patterns and predictors of cholinesterase inhibitor (ChEI) prescribing in Dementia with Lewy bodies (DLB) patients.…
  • 2025 International Congress

    Stratification study of alpha-synucleinopathy by body fluid biomarkers

    R. Kamo, A. Okuzumi, M. Iseki, T. Hatano, N. Hattori (Tokyo, Japan)

    Objective: This study aims to stratify patients with Parkinson's disease (PD) based on clinical features and several disease-associated biomarkers by analyzing the relationship between biomarkers,…
  • 2025 International Congress

    Development of the Lewy Body Dementia Domain Rating Scale (LBD-DRS): A disease-specific outcome measure

    E. Matar, B. Boeve, J. Kane, F. Rodriguez-Porcel, A. Schrag, S. Sikkes, J. Taylor (New South Wales, Australia)

    Objective: To develop and refine the Lewy Body Dementia Domain Rating Scale (LBD-DRS) as a disease-specific outcome measure tailored to the unique clinical features of…
  • 2025 International Congress

    Neural Signatures of Hallucination Emergence in Dementia with Lewy Bodies

    R. Vin, S. Moret, HY. Yi, M. Lawrence, V. Santini, J. Cedarbaum, A. Powers, C. Fredericks (New Haven, USA)

    Objective: REM sleep behavior disorder (RBD) is a prodromal state for alpha-synucleinopathy. Here, we present a behavioral marker for hallucination propensity that distinguishes Dementia with…
  • 2025 International Congress

    Advancing LBD Diagnosis: EEG Biomarkers for Cognitive Fluctuations

    H. Mayo, A. Negida, M. Ahsan, S. Lageman, N. Mukhopadhyay, M. Barrett (Richmond, USA)

    Objective: The objective of the study was to identify EEG features associated with cognitive fluctuations in patients with Lewy body dementia (LBD). Background: Cognitive fluctuations…
  • 2025 International Congress

    Immune cell changes in early Dementia with Lewy Bodies

    T. Yacoubian, H. Qin, A. Amara, N. Stover, L. Ruffrage, M. Dean, Y. Zhang, R. Kennedy, D. Geldmacher, A. Gerstenecker, D. Standaert, E. Benveniste (AURORA, USA)

    Objective: To examine if immune cell changes are present in early stages of Dementia with Lewy Bodies (DLB). Background: Evidence for inflammation in synucleinopathies has…
  • 2025 International Congress

    Modulation of working memory in prodromal DLB by non-invasive brain stimulation of the striatum and cerebellum

    I. Rektorová, M. Pupikova, . Gajdoš (Brno, Czech Republic)

    Objective: We aimed to modulate working memory (WM) in patients with MCI with Lewy bodies (MCI-LB) by non-invasive stimulation of the striatum with or without…
  • 2025 International Congress

    Sex Differences for Autopsy-Confirmed Prodromal Lewy Body Dementia

    F. Dino, L. Gunn-Sandell, A. Tsai, D. Carter, Y. Wang, E. Bayram (Aurora, USA)

    Objective: To assess sex differences in prodromal Lewy body dementia (LBD) compared to Alzheimer’s disease (AD) Background: Identifying LBD at the prodromal stage can provide…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 23
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley